U.S. markets close in 5 hours 11 minutes
  • S&P 500

    3,301.60
    +30.57 (+0.93%)
     
  • Dow 30

    26,667.98
    +148.03 (+0.56%)
     
  • Nasdaq

    11,123.45
    +118.59 (+1.08%)
     
  • Russell 2000

    1,548.75
    +5.47 (+0.35%)
     
  • Crude Oil

    36.00
    -1.39 (-3.72%)
     
  • Gold

    1,875.00
    -4.20 (-0.22%)
     
  • Silver

    23.43
    +0.07 (+0.30%)
     
  • EUR/USD

    1.1689
    -0.0060 (-0.51%)
     
  • 10-Yr Bond

    0.7910
    +0.0100 (+1.28%)
     
  • GBP/USD

    1.2928
    -0.0060 (-0.46%)
     
  • USD/JPY

    104.4720
    +0.1710 (+0.16%)
     
  • BTC-USD

    13,450.22
    +286.83 (+2.18%)
     
  • CMC Crypto 200

    264.93
    +22.25 (+9.17%)
     
  • FTSE 100

    5,596.06
    +13.26 (+0.24%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

A Look at the Production of Ebola Drug


It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories.

Using plants this way - sometimes called "pharming" -- can produce complex and valuable proteins for medicines. That approach, studied for about 20 years, hasn't caught on widely in the pharmaceutical industry.

But some companies and academic labs are pursuing it to create medicines and vaccines against such targets as HIV, cancer, the deadly Marburg virus and norovirus, known for causing outbreaks of stomach bug on cruise ships, as well as Ebola.
Related Stories


Reporting by Malcolm Ritter, The Associated Press.